Improving children’s medicines through research and education

The Children’s Medicines Centre (CMC) will improve the use of medicines for children and young people (CYP) through collaborative research and training.

The CMC will focus on research on:

  • Use of real-world data and data modelling to inform new drugs trials and define dosing for current drugs with little or no evidence base
  • Physical drug analysis to support drug dose finding
  • 3D-Drug printing
  • Analyse reports in NHS England’s central database to quantify medicine risk and use safety modelling to define and publish improvement solutions.

Education

  • Build skills and capacity around medicines across the Multidisciplinary Team. This is being achieved by supporting and developing:
    • paediatric consultant pharmacists
    • medicine centric clinical academics
    • medical clinical pharmacologists
    • national and international internships and masterclasses
    • academic development of specialist paediatric pharmacists.

Practice

  • Champion and define mechanisms of reducing the carbon footprint and environmental damage of medicines​
  • Enhance paediatric medicine services through innovation, robotics and AI
  • With patient and public involvement and engagement (PPIE), enhance medicine information content and delivery for children and parents. This can help to improve patient satisfaction, and patient compliance.